Cidara Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference
Cidara Therapeutics (Nasdaq: CDTX), a biotechnology company specializing in drug-Fc conjugate immunotherapies through its Cloudbreak® platform, has announced its participation in the 24th Annual Needham Virtual Healthcare Conference.
The company will deliver a presentation on Wednesday, April 9, 2025, at 11:00 AM ET. The presentation will be accessible via webcast, with a replay available in the Investors section of Cidara's website for 90 days following the event.
Additionally, Cidara's management team will engage in one-on-one investor meetings during the conference. Interested investors should coordinate with their Needham representatives to schedule meetings.
Cidara Therapeutics (Nasdaq: CDTX), un'azienda biotecnologica specializzata in immunoterapie con coniugati farmaco-Fc attraverso la sua piattaforma Cloudbreak®, ha annunciato la sua partecipazione alla 24ª Conferenza Virtuale Annuale di Needham sulla Salute.
L'azienda presenterà il suo intervento mercoledì 9 aprile 2025, alle 11:00 AM ET. La presentazione sarà accessibile tramite webcast, con una registrazione disponibile nella sezione Investitori del sito web di Cidara per 90 giorni dopo l'evento.
Inoltre, il team di gestione di Cidara parteciperà a incontri individuali con gli investitori durante la conferenza. Gli investitori interessati dovrebbero coordinarsi con i loro rappresentanti di Needham per pianificare gli incontri.
Cidara Therapeutics (Nasdaq: CDTX), una empresa biotecnológica especializada en inmunoterapias con conjugados de fármaco-Fc a través de su plataforma Cloudbreak®, ha anunciado su participación en la 24ª Conferencia Virtual Anual de Needham sobre Salud.
La empresa realizará una presentación el miércoles 9 de abril de 2025, a las 11:00 AM ET. La presentación será accesible a través de un webcast, con una repetición disponible en la sección de Inversores del sitio web de Cidara durante 90 días después del evento.
Además, el equipo de gestión de Cidara participará en reuniones individuales con inversores durante la conferencia. Los inversores interesados deben coordinarse con sus representantes de Needham para programar las reuniones.
시다라 테라퓨틱스 (Nasdaq: CDTX), 약물-Fc 결합 면역 요법을 전문으로 하는 생명공학 회사가 Cloudbreak® 플랫폼을 통해 제24회 니드햄 연례 가상 헬스케어 컨퍼런스에 참여한다고 발표했습니다.
회사는 2025년 4월 9일 수요일 오전 11시(ET)에 발표를 진행할 예정입니다. 발표는 웹캐스트를 통해 접근할 수 있으며, 이벤트 후 90일 동안 시다라 웹사이트의 투자자 섹션에서 다시 볼 수 있습니다.
또한, 시다라의 경영진은 컨퍼런스 동안 개별 투자자 미팅에 참여할 예정입니다. 관심 있는 투자자는 미팅 일정을 잡기 위해 니드햄 대표와 조율해야 합니다.
Cidara Therapeutics (Nasdaq: CDTX), une entreprise de biotechnologie spécialisée dans les immunothérapies par conjugés médicament-Fc via sa plateforme Cloudbreak®, a annoncé sa participation à la 24e Conférence Virtuelle Annuelle de Needham sur la Santé.
L'entreprise fera une présentation le mercredi 9 avril 2025, à 11h00 ET. La présentation sera accessible par webcast, avec un replay disponible dans la section Investisseurs du site web de Cidara pendant 90 jours après l'événement.
De plus, l'équipe de direction de Cidara participera à des réunions individuelles avec des investisseurs pendant la conférence. Les investisseurs intéressés doivent se coordonner avec leurs représentants Needham pour planifier les réunions.
Cidara Therapeutics (Nasdaq: CDTX), ein Biotechnologieunternehmen, das sich auf Arzneimittel-Fc-Konjugat-Immuntherapien über seine Cloudbreak®-Plattform spezialisiert hat, hat seine Teilnahme an der 24. jährlichen virtuellen Needham Gesundheitskonferenz angekündigt.
Das Unternehmen wird am Mittwoch, den 9. April 2025, um 11:00 Uhr ET eine Präsentation halten. Die Präsentation wird über einen Webcast zugänglich sein, mit einer Wiederholung, die 90 Tage nach der Veranstaltung im Investorenbereich der Cidara-Website verfügbar ist.
Darüber hinaus wird das Management-Team von Cidara während der Konferenz an eins-zu-eins-Investorenmeetings teilnehmen. Interessierte Investoren sollten sich mit ihren Needham-Vertretern abstimmen, um Meetings zu planen.
- None.
- None.
SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies, today announced that company management will participate in the 24th Annual Needham Virtual Healthcare Conference.
Details are as follows:
Event: 24th Annual Needham Virtual Healthcare Conference
Date: Wednesday, April 9, 2025
Time: 11:00 AM ET
Format: Presentation
Webcast: https://wsw.com/webcast/needham146/cdtx/2261559
A replay of the presentation will be available in the Investors section on the Company’s website at www.cidara.com. The replay of the presentation will be available for 90 days.
Cidara will also participate in one-on-one investor meetings during this event. Investors interested in meeting with Cidara at the conference should contact their Needham representative directly.
About Cidara Therapeutics
Cidara Therapeutics is using its proprietary Cloudbreak® platform to develop novel drug-Fc conjugates (DFCs) comprising targeted small molecules or peptides coupled to a proprietary human antibody fragment (Fc). Cidara’s lead DFC candidate, CD388, is a long-acting antiviral designed to achieve universal prevention of seasonal and pandemic influenza with a single dose by directly inhibiting viral proliferation. In June 2023, CD388 was granted Fast Track Designation by the U.S. Food and Drug Administration (FDA). The Company announced completion of enrollment of its 5000 patient Phase 2b NAVIGATE trial in December 2024. Additional DFCs have been developed for oncology and in July 2024 Cidara received IND clearance for CBO421 which is intended to target CD73 in solid tumors. Cidara is headquartered in San Diego, California. For more information, please visit www.cidara.com.
INVESTOR CONTACT:
Brian Ritchie
LifeSci Advisors
(212) 915-2578
britchie@lifesciadvisors.com
MEDIA CONTACT:
Michael Fitzhugh
LifeSci Communications
mfitzhugh@lifescicomms.com
FAQ
When is Cidara Therapeutics (CDTX) presenting at the Needham Healthcare Conference 2025?
How can investors access CDTX's Needham Conference presentation webcast?
How long will CDTX's Needham Conference presentation replay be available?
How can investors schedule one-on-one meetings with CDTX management at the Needham Conference?
What is the main technology platform that CDTX is developing?
